Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release May 05 2026

· Issued by Caplin Point Laboratories Limited

Filed with NSE · · 3 pages · English

Release

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for Calcium Gluconate Injection USP".

Caplin Point Laboratories Limited on 6ix

Earlier from Caplin Point Laboratories

Later from Caplin Point Laboratories

All Caplin Point Laboratories news releases